Dr. John Jurige | M.D. The last 15 years have seen tremendous changes in the evaluation and treatment of prostate cancer. We have more effective methods to evaluate and diagnose men at risk. We understand the biological behavior of the disease better and can finally offer less invasive precise therapy to many men. The most…
read more
Dr. John Jurige | M.D. First Urology is the first in the region to provide MRI/ultrasound fusion biopsy. This advanced technology allows for a more precise assessment of the prostate in order to more accurately determine the presence or absence of prostate cancer. In addition, the precise location and extent of cancers can be determined, which…
read more
Data Indicate Prostate Cancer Screening Saves Lives. Medscape (4/24, Johnson) reports, “For the first time, updated results from the European Randomized Study of Screening for Prostate Cancer (ERSPC), the largest randomized prostate cancer screening trial in the world, show a significant survival advantage with prostate-specific antigen (PSA) screening for men from 50 to 74 years of…
read more
Dr. Bradley Bell The AUA (American Urological Association) has published their recommendations regarding PSA (Prostatic Specific Antigen) screening for men to detect prostate cancer. These recommendations state that patients should be informed of the risks and benefits of using the PSA to screen for prostate cancer. The benefits are obviously to detect prostate cancer early…
read more
Dr. John Jurige Jr. In May 2012, a government organization known as the United States Preventive Services Task Force issued a statement concluding that routine PSA testing for prostate cancer was not warranted. Most urologists – the physicians who are extensively trained to evaluate, counsel and treat men with prostate cancer – are strongly opposed…
read more